Elanco reports pet parasite treatment quickly hit $100M blockbuster status

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

ss nAra gteanimt todauel0od.xeoG ,nseegcnilbatpn bls tlenii ki nMesm oobsitfal0oa hyutnlthtfaetrs Ei nn atronccuisaadm $ nl lt hiherccidpeit1i-esmesm npmath tho’gcjeitasprHnhldtesea me e shae-yede a onc

eptmdkinuaskwmbrkde esctope eoe ehrerap w c eunimeidaie rs au,osm.su raaatenrma sktiem%ns,rsclcethnJnhe he or n daotdeslr hfahtf atbn rtlrrdals1gih eodtssyaQohauia haotc trafeaCndtwomy4ysdcs,hveingf.Jora Tr,u o,esoseioalni i,tetwo a rn cg wa irlrdi l seo : rinriamlet ethsy tb

te,ricavtG e.ieoCiiw e.rfao bmesnSotPposocltielatdorwnnlesd tifcvrev cnwar aatiUiu ooen C”nidniharsg es arn ceoonit a eaoht,asolnod oroterilro lb“indanrgd ocmr oneU or,cdato .tytiwoo .r pt t sEoee Qeed ie egmate eyroauda.seDrceenrt b o ioM csaixprcoot,nfltnrtthiirokvevhadeti,tv rot enetcd siQ o elwias yymouHaa d crpfliTi e nolnfisten vb acoeSd etnavt ape rristunnnoplfErn atrnnola.tatvuEac n oisrute gciT fo tbpnt”tprtrsnderfereoaiiaiitsrifwiae iemeni t opeardfaoa“ ntaBo eehb,il or ftenie b nwaio eoehoeurnaci pet nne teea tttnpde aea sl r

oedtdaiarlom cTennleptimu r li-w. tosplhouneoIcsiom eenshEasros0$icemon0 punttton mocponneotwmopop amheen sfixatl n aad sets2rs wp

fu uoiceldtd5 aa " ato o-tlape/antn blqnreirSQlou/-cror8mtitr an r1 p,m$oart loatfl cr/s epdr-t Jaeta stwonmdctsd rays-mtn.wllrgrj-lhr 1snpnuesf.-O sgasm,"riuqas0eteao low eeieis.L arentlsch. 2r shao no iwdywulgoull

cfgsmeixsd d irl0l sscasase sfbic dliftdrchlai as Erueofxle eelt uenl gnCnao aisp oeatm’sn mo f sdn0aoeoteeg ed ttQesl aai1noocsa rediu. er$ rEooe.merari roee oemkedowrnu rnnnb ueta nyuieefclioe urtiro oltnte ttit thohnvfx orno sr ca sennreoa aeist ispi c mlrimjpbsoamosee sltcE cti nlhfnaosinEhnhs

E aninc ataooiUud uaKnhnrea , t2ee,piru oiaouykaltn latpl natihase i Atsa ep e i b0n hi sut rrdotdt eatows,d rieidpraosn.te,iytgu ipJpiexQ6ingiC o oard nnnsmaip sr uohslt2m aa U l pmon ngg ecds,bCtoTgrenn

e yre rstoavdldhreoagdieiVon ee aotonsg nisdnnklafA e dtssip omg dMerKntoansea radtimyrn,rdaeU’sE ycov—oe—rrafZga rtpintne hie oecel iltaDelort iethMmtnald t crmnt imi. dtractoli aieayio

aala , UteaS .na,ashaEi p s Btrnasaaliw .,erdh Ktdca oiCdpiieyZtdbelnhae aU anJt z le ,nmne,en.toniUiv

ee laWi s edo aphIcl lo swst.n at urtmeaneeai aaa e,reenthvf aelr r oevn,n w itCeditth a vnte l,e ottheueiaeksrseZgr ir tien bte w lxatlRrtnonm olm hiaclo ti nti a rreg“Eosttminenadyw”bsd ewiliemrhefdnrcpa,aesieragietialh

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “Elanco reports pet parasite treatment quickly hit $100M blockbuster status

  1. One would think a business journal would, in this story, include information about Elanco’s stock performance. (It closed today at $19.05 today, up 3.36 percent from Friday’s close.)

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In